The treatment and survival of new drugs have improved significantly in the treatment and survival of set cell lymphoma
-
Last Update: 2020-06-11
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
set of cell lymphoma (mantle cell lymphoma, MCL) has changed dramatically in recent years, with clinical results showing a significant increase in patient survivalrecently, scientists from the University of York in the Uk and other institutions investigated first-line and recurrent/recurrent (RR) disease management in 335 patients diagnosed with MCL between 2004 and 2015, as well as collecting information about their demographics, diagnoses and prognosisresearchers observed significant improvements in patient treatment and survival, such as the use of first-linedrugs(rituxima monotherapy increased from 32 percent to 86 percent over 11 years) and median survival increased from two years in 2004-2011 to 3.5 years in 2012-2015There has also been a marked improvement in the results of treatment for RR disease, from 8 months in 2004-2011 to 16.8 months in 2012-2015, in line with the introduction of drugs such as benzostine and errutinibmore encouraging is the significant improvement in the prognosis for patients of all ages, with the overall survival rate of patients over 70 years of age with RR disease almost doubling in the year after treatmentthe results of the study show that it is important to monitornew drug(or changes in treatment changes to clinical outcomes)
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
